NO20030795D0 - Kinazolinderivater - Google Patents

Kinazolinderivater

Info

Publication number: NO20030795D0
Authority: NO; Norway
Prior art keywords: quinazoline
Prior art date: 2000-08-21

Application number

NO20030795A

Other languages

English (en)

Other versions

NO20030795L (no

NO326515B1 (no

Inventor

Laurent Francois And Hennequin

Patrick Ple

Christine Marie Paul Lambert

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-21

Filing date

2003-02-20

Publication date

2003-02-20

2003-02-20 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-02-20 Publication of NO20030795D0 publication Critical patent/NO20030795D0/no

2003-04-04 Publication of NO20030795L publication Critical patent/NO20030795L/no

2008-12-22 Publication of NO326515B1 publication Critical patent/NO326515B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20030795A 2000-08-21 2003-02-20 Kinazolinderivater, anvendelse og fremstilling derav, samt farmasoytisk preparat NO326515B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP00402320		2000-08-21
EP01401006		2001-04-19
PCT/GB2001/003649 WO2002016352A1 (en)	2000-08-21	2001-08-15	Quinazoline derivatives

Publications (3)

Publication Number	Publication Date
NO20030795D0 true NO20030795D0 (no)	2003-02-20
NO20030795L NO20030795L (no)	2003-04-04
NO326515B1 NO326515B1 (no)	2008-12-22

Family

ID=26073540

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030795A NO326515B1 (no)	2000-08-21	2003-02-20	Kinazolinderivater, anvendelse og fremstilling derav, samt farmasoytisk preparat

Country Status (21)

Country	Link
US (1)	US7115615B2 (no)
EP (1)	EP1313727A1 (no)
JP (1)	JP2004506732A (no)
KR (2)	KR20080027400A (no)
CN (1)	CN100347169C (no)
AR (1)	AR033560A1 (no)
AU (2)	AU7860901A (no)
BR (1)	BR0113358A (no)
CA (1)	CA2419301C (no)
CZ (1)	CZ2003486A3 (no)
EE (1)	EE05387B1 (no)
IL (2)	IL154131A0 (no)
MX (1)	MXPA03001332A (no)
MY (1)	MY129809A (no)
NO (1)	NO326515B1 (no)
NZ (1)	NZ523702A (no)
PL (1)	PL202812B1 (no)
RU (1)	RU2267489C2 (no)
SK (1)	SK2142003A3 (no)
TW (1)	TWI280960B (no)
WO (1)	WO2002016352A1 (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA73993C2 (uk)	2000-06-06	2005-10-17	Астразенека Аб	Хіназолінові похідні для лікування пухлин та фармацевтична композиція
EP1326860A1 (en)	2000-10-13	2003-07-16	AstraZeneca AB	Quinazoline derivatives
EP1326859A1 (en)	2000-10-13	2003-07-16	AstraZeneca AB	Quinazoline derivatives with anti-tumour activity
AU2002217999A1 (en)	2000-11-01	2002-05-15	Cor Therapeutics, Inc.	Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides
EP1381599B1 (en) *	2001-04-19	2008-09-24	Astrazeneca AB	Quinazoline derivatives
JP4326328B2 (ja)	2001-07-16	2009-09-02	アストラゼネカアクチボラグ	キノリン誘導体及びそれらのチロシンキナーゼ阻害薬としての使用
GB0128109D0 (en) *	2001-11-23	2002-01-16	Astrazeneca Ab	Therapeutic use
AU2002365664A1 (en) *	2001-12-05	2003-06-17	Astrazeneca Ab	Quinoline derivatives as antitumour agents
NZ534171A (en) *	2002-02-01	2007-06-29	Astrazeneca Ab	Quinazoline compounds for the treatment of diseases associated with angiogenesis and/or increased vascular permeability
TWI324597B (en) *	2002-03-28	2010-05-11	Astrazeneca Ab	Quinazoline derivatives
US6924285B2 (en)	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
GB0215823D0 (en)	2002-07-09	2002-08-14	Astrazeneca Ab	Quinazoline derivatives
DE60327323D1 (de) *	2002-07-09	2009-06-04	Astrazeneca Ab	Chinazoline derivative und ihre anwendung in der krebsbehandlung
WO2004006846A2 (en)	2002-07-15	2004-01-22	Exelixis, Inc.	Receptor-type kinase modulators and methods of use
GB0225579D0 (en) *	2002-11-02	2002-12-11	Astrazeneca Ab	Chemical compounds
CA2503371C (en)	2002-11-04	2011-01-11	Astrazeneca Ab	Quinazoline derivatives as src tyrosine kinase inhibitors
CN100354278C (zh) *	2002-11-04	2007-12-12	阿斯利康(瑞典)有限公司	作为src酪氨酸激酶抑制剂的喹唑啉衍生物
RS20060097A (en)	2002-12-20	2008-11-28	Pfizer Products Inc.,	Pyrimidine derivatives for the treatment of abnormal cell growth
US7109337B2 (en)	2002-12-20	2006-09-19	Pfizer Inc	Pyrimidine derivatives for the treatment of abnormal cell growth
GB0307333D0 (en) *	2003-03-29	2003-05-07	Astrazeneca Ab	Therapeutic agent
GB0310401D0 (en) *	2003-05-07	2003-06-11	Astrazeneca Ab	Therapeutic agent
GB0317665D0 (en)	2003-07-29	2003-09-03	Astrazeneca Ab	Qinazoline derivatives
WO2005030140A2 (en)	2003-09-26	2005-04-07	Exelixis, Inc.	C-met modulators and methods of use
ES2315834T3 (es)	2004-02-03	2009-04-01	Astrazeneca Ab	Derivados de quinazolina.
WO2005111022A1 (en)	2004-05-14	2005-11-24	Pfizer Products Inc.	Pyrimidines derivatives for the treatment of abnormal cell growth
WO2005111016A1 (en)	2004-05-14	2005-11-24	Pfizer Products Inc.	Pyrimidine derivatives for the treatment of abnormal cell growth
WO2005111024A1 (en)	2004-05-14	2005-11-24	Pfizer Products Inc.	Pyrimidine derivatives for the treatment of abnormal cell growth
PA8649401A1 (es) *	2004-10-13	2006-09-22	Wyeth Corp	Analogos de anilino-pirimidina
GB0427697D0 (en)	2004-12-17	2005-01-19	Astrazeneca Ab	Chemical process
CN101243030B (zh) *	2005-08-17	2012-02-01	宇部兴产株式会社	4-卤代邻苯二酚化合物的制备方法
MX2009000456A (es) *	2006-07-13	2009-01-27	Janssen Pharmaceutica Nv	Derivados de quinazolina mtki.
EP1921070A1 (de)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
EP2425840B1 (en)	2006-12-15	2015-04-08	Abraxis BioScience, Inc.	Triazine derivatives and their therapeutical applications
MX2009007610A (es)	2007-02-06	2009-07-24	Boehringer Ingelheim Int	Heterociclicos biciclicos, medicamentos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion.
BRPI0907916A2 (pt)	2008-02-07	2015-07-28	Boehringer Ingelheim Int	Heterociclos espirociclos, medicamentos contendo esses compostos, e processos para preparar os mesmos
BRPI0912170A2 (pt)	2008-05-13	2015-10-13	Astrazeneca Ab	composto, forma a, processo para a preparação da mesma, composição farmacêutica, uso de um composto, e, método para tratar um câncer em um animal de sangue quente
CA2733153C (en)	2008-08-08	2016-11-08	Boehringer Ingelheim International Gmbh	Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
US20100069340A1 (en) *	2008-09-11	2010-03-18	Wyeth	Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor
AU2009295948B2 (en) *	2008-09-29	2013-12-05	GlaxoSmithKline, LLC	Quinazolinone, quinolone and related analogs as sirtuin modulators
NZ618004A (en)	2009-01-16	2015-06-26	Exelixis Inc	Malate salt of n-(4-{ [6,7-bis(methyloxy)quinolin-4-yl]oxy} phenyl)-n’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
KR20120026612A (ko)	2009-06-09	2012-03-19	아브락시스 바이오사이언스, 엘엘씨	벤질 치환 트리아진 유도체와 이들의 치료적 용도
CN102573480B (zh)	2009-06-09	2015-06-10	加利福尼亚资本权益有限责任公司	三嗪衍生物及其治疗应用
UA108618C2 (uk)	2009-08-07	2015-05-25		Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
CN102617463A (zh) *	2012-02-28	2012-08-01	苏州卡耐博生物技术有限公司	喹啉衍生物和喹唑啉衍生物及它们的制备方法
CN108064274A (zh)	2014-07-30	2018-05-22	耶达研究及发展有限公司	用于培养多能干细胞的培养基
PL3781561T3 (pl)	2018-04-18	2024-07-22	Constellation Pharmaceuticals, Inc.	Modulatory enzymów modyfikujących grupę metylową, kompozycje i ich zastosowania
CA3100977A1 (en)	2018-05-21	2019-11-28	Constellation Pharmaceuticals, Inc.	Modulators of methyl modifying enzymes, compositions and uses thereof
EP3914698A1 (en)	2019-01-23	2021-12-01	Yeda Research and Development Co. Ltd	Culture media for pluripotent stem cells
CN116120273A (zh) *	2023-02-15	2023-05-16	爱斯特（成都）生物制药股份有限公司	一种制备5-溴苯并[d][1,3]二氧-4-胺的方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL89029A (en)	1988-01-29	1993-01-31	Lilly Co Eli	Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
US5411963A (en)	1988-01-29	1995-05-02	Dowelanco	Quinazoline derivatives
US5710158A (en)	1991-05-10	1998-01-20	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US5721237A (en)	1991-05-10	1998-02-24	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
US5409930A (en)	1991-05-10	1995-04-25	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
NZ243082A (en)	1991-06-28	1995-02-24	Ici Plc	4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
PT100905A (pt)	1991-09-30	1994-02-28	Eisai Co Ltd	Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
AU661533B2 (en)	1992-01-20	1995-07-27	Astrazeneca Ab	Quinazoline derivatives
GB9323290D0 (en)	1992-12-10	1994-01-05	Zeneca Ltd	Quinazoline derivatives
KR100225721B1 (ko)	1994-02-23	1999-10-15	디. 제이. 우드, 스피겔 알렌 제이	4-헤테로사이클릴-치환된 퀴나졸린 유도체, 이들의 제조 방법 및항암제로서의 용도
WO1995024190A2 (en) *	1994-03-07	1995-09-14	Sugen, Inc.	Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
GB9510757D0 (en)	1994-09-19	1995-07-19	Wellcome Found	Therapeuticaly active compounds
TW321649B (no)	1994-11-12	1997-12-01	Zeneca Ltd
GB2295387A (en)	1994-11-23	1996-05-29	Glaxo Inc	Quinazoline antagonists of alpha 1c adrenergic receptors
GB9424233D0 (en)	1994-11-30	1995-01-18	Zeneca Ltd	Quinazoline derivatives
DE122005000053I2 (de)	1995-03-30	2008-01-17	Pfizer Prod Inc	Chinazolinderivate
US6046206A (en)	1995-06-07	2000-04-04	Cell Pathways, Inc.	Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
GB9514265D0 (en)	1995-07-13	1995-09-13	Wellcome Found	Hetrocyclic compounds
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
US5760041A (en)	1996-02-05	1998-06-02	American Cyanamid Company	4-aminoquinazoline EGFR Inhibitors
NZ330868A (en)	1996-02-13	2000-01-28	Zeneca Ltd	4-phenoxy, phenylthio or phenylamino substituted quinazoline derivatives ane medicaments useful as VEGF inhibitors
GB9603095D0 (en)	1996-02-14	1996-04-10	Zeneca Ltd	Quinazoline derivatives
GB9603097D0 (en)	1996-02-14	1996-04-10	Zeneca Ltd	Quinazoline compounds
GB9607729D0 (en) *	1996-04-13	1996-06-19	Zeneca Ltd	Quinazoline derivatives
PT912559E (pt)	1996-07-13	2003-03-31	Glaxo Group Ltd	Compostos heterociclicos fundidos como inibidores de proteina tirosina quinase
AUPO257096A0 (en) *	1996-09-25	1996-10-17	Bhp Steel (Jla) Pty Limited	Production of striped coatings on strip
GB9718972D0 (en)	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
EP0837063A1 (en)	1996-10-17	1998-04-22	Pfizer Inc.	4-Aminoquinazoline derivatives
AR012634A1 (es)	1997-05-02	2000-11-08	Sugen Inc	Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
TW436485B (en)	1997-08-01	2001-05-28	American Cyanamid Co	Substituted quinazoline derivatives
WO1999061428A1 (en)	1998-05-28	1999-12-02	Parker Hughes Institute	Quinazolines for treating brain tumor
JP2004504259A (ja)	1998-06-30	2004-02-12	パーカー　ヒューズ　インスティテュート	Ｊａｋ−３インヒビターを用いたｃ−ｊｕｎ発現の阻害方法
CA2342503A1 (en)	1998-08-21	2000-03-02	Parker Hughes Institute	Quinazoline derivatives
US7262201B1 (en)	1998-10-08	2007-08-28	Astrazeneca Ab	Quinazoline derivatives
IL132366A0 (en) *	1998-10-15	2001-03-19	Cell Pathways Inc	Methods for identifying compounds for inhibition of neoplastic lesions and pharmaceutical compositions containing such compounds
ATE482946T1 (de) *	1999-02-10	2010-10-15	Astrazeneca Ab	Chinazolinderivate als angiogenesehemmer und zwischenprodukte dafür
HUP0301132A3 (en)	1999-02-27	2004-03-29	Boehringer Ingelheim Pharma	4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases, process for their preparation their use and pharmaceutical compositions containing them
US6080747A (en)	1999-03-05	2000-06-27	Hughes Institute	JAK-3 inhibitors for treating allergic disorders
DE19911509A1 (de)	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
WO2001021596A1 (en)	1999-09-21	2001-03-29	Astrazeneca Ab	Quinazoline derivatives and their use as pharmaceuticals
BR0014133A (pt)	1999-09-21	2002-06-11	Astrazeneca Ab	Uso de um composto, composto, métodos de preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
GB9922173D0 (en)	1999-09-21	1999-11-17	Zeneca Ltd	Chemical compounds
ATE334973T1 (de)	2000-04-07	2006-08-15	Astrazeneca Ab	Chinazolinverbindungen
UA73993C2 (uk)	2000-06-06	2005-10-17	Астразенека Аб	Хіназолінові похідні для лікування пухлин та фармацевтична композиція
EP1326859A1 (en)	2000-10-13	2003-07-16	AstraZeneca AB	Quinazoline derivatives with anti-tumour activity
EP1326860A1 (en)	2000-10-13	2003-07-16	AstraZeneca AB	Quinazoline derivatives
AU2002212436A1 (en)	2000-10-25	2002-05-06	Astrazeneca Ab	Quinazoline derivatives
EP1381599B1 (en)	2001-04-19	2008-09-24	Astrazeneca AB	Quinazoline derivatives
JP4326328B2 (ja)	2001-07-16	2009-09-02	アストラゼネカアクチボラグ	キノリン誘導体及びそれらのチロシンキナーゼ阻害薬としての使用

2001
- 2001-08-15 CN CNB018177409A patent/CN100347169C/zh not_active Expired - Fee Related
- 2001-08-15 RU RU2003107683/04A patent/RU2267489C2/ru not_active IP Right Cessation
- 2001-08-15 US US10/344,678 patent/US7115615B2/en not_active Expired - Fee Related
- 2001-08-15 KR KR1020087005460A patent/KR20080027400A/ko not_active Application Discontinuation
- 2001-08-15 MX MXPA03001332A patent/MXPA03001332A/es active IP Right Grant
- 2001-08-15 WO PCT/GB2001/003649 patent/WO2002016352A1/en active IP Right Grant
- 2001-08-15 AU AU7860901A patent/AU7860901A/xx active Pending
- 2001-08-15 EE EEP200300071A patent/EE05387B1/xx not_active IP Right Cessation
- 2001-08-15 JP JP2002521453A patent/JP2004506732A/ja not_active Ceased
- 2001-08-15 SK SK214-2003A patent/SK2142003A3/sk not_active Application Discontinuation
- 2001-08-15 CZ CZ2003486A patent/CZ2003486A3/cs unknown
- 2001-08-15 EP EP01956688A patent/EP1313727A1/en not_active Withdrawn
- 2001-08-15 AU AU2001278609A patent/AU2001278609B2/en not_active Ceased
- 2001-08-15 IL IL15413101A patent/IL154131A0/xx unknown
- 2001-08-15 NZ NZ523702A patent/NZ523702A/en unknown
- 2001-08-15 CA CA002419301A patent/CA2419301C/en not_active Expired - Fee Related
- 2001-08-15 KR KR1020037002441A patent/KR100821446B1/ko not_active IP Right Cessation
- 2001-08-15 BR BR0113358-6A patent/BR0113358A/pt not_active Application Discontinuation
- 2001-08-15 PL PL360591A patent/PL202812B1/pl not_active IP Right Cessation
- 2001-08-20 MY MYPI20013907A patent/MY129809A/en unknown
- 2001-08-21 AR ARP010103972A patent/AR033560A1/es not_active Application Discontinuation
- 2001-09-14 TW TW90122895A patent/TWI280960B/zh not_active IP Right Cessation
2003
- 2003-01-26 IL IL154131A patent/IL154131A/en not_active IP Right Cessation
- 2003-02-20 NO NO20030795A patent/NO326515B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
MXPA03001332A (es)	2004-07-08
NO20030795L (no)	2003-04-04
NZ523702A (en)	2004-08-27
CA2419301C (en)	2009-12-08
BR0113358A (pt)	2003-07-01
IL154131A0 (en)	2003-07-31
KR20080027400A (ko)	2008-03-26
EE05387B1 (et)	2011-02-15
PL360591A1 (en)	2004-09-06
AR033560A1 (es)	2003-12-26
AU2001278609B2 (en)	2005-04-14
KR20030022416A (ko)	2003-03-15
NO326515B1 (no)	2008-12-22
CZ2003486A3 (cs)	2003-05-14
CA2419301A1 (en)	2002-02-28
JP2004506732A (ja)	2004-03-04
CN1471527A (zh)	2004-01-28
AU7860901A (en)	2002-03-04
IL154131A (en)	2010-04-15
RU2267489C2 (ru)	2006-01-10
US20040034046A1 (en)	2004-02-19
PL202812B1 (pl)	2009-07-31
US7115615B2 (en)	2006-10-03
EE200300071A (et)	2004-12-15
TWI280960B (en)	2007-05-11
MY129809A (en)	2007-05-31
EP1313727A1 (en)	2003-05-28
SK2142003A3 (en)	2003-07-01
KR100821446B1 (ko)	2008-04-10
CN100347169C (zh)	2007-11-07
WO2002016352A1 (en)	2002-02-28

Publication	Publication Date	Title
NL300999I2 (nl)	2019-08-28	macimorelin
NO20030795L (no)	2003-04-04	Kinazolinderivater
ATE290000T1 (de)	2005-03-15	Muscarinagonisten
ATE252099T1 (de)	2003-11-15	Biarylcarboxamide
DE10136334B8 (de)	2009-11-26	Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de)	2005-12-15	Thiazinoxazolidinon
DE60128645D1 (de)	2007-07-12	Rotor-Schaufelblatt-Zusammenbau
ATA2932001A (de)	2004-11-15	Schneefräse
DE50100710D1 (de)	2003-11-06	Wischblatt
NO20030276L (no)	2003-03-18	Fremgangsmåte
ATE262530T1 (de)	2004-04-15	Indolochinazolinone
ATE298751T1 (de)	2005-07-15	7-oxopyridoryrimidine
AR028336A1 (es)	2003-05-07	4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE10192638T1 (de)	2002-10-31	Bohrstangenladevorrichtung
NO20035573D0 (no)	2003-12-12	Kinazolinderivater
ATE509008T1 (de)	2011-05-15	Sulfonylguanidine
DE10196064T1 (de)	2003-03-13	Halbleiterfotodektionsgerät
DE50011511D1 (de)	2005-12-08	Blowby-Heizung
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es)	2003-04-16	Antitranspirantes
ATE476423T1 (de)	2010-08-15	Benzoylpyridazine
DE50007634D1 (de)	2004-10-07	Kardioplegieballonkatheter
DE10195909T1 (de)	2003-02-20	Viehfüttervorrichtung
DE10085445T1 (de)	2003-02-27	Drahterodierbearbeitungseinrichtung
AR027982A1 (es)	2003-04-23	Aril- y heteroarilsulfonatos

Legal Events

Date	Code	Title	Description
2012-03-26	MM1K	Lapsed by not paying the annual fees